Quantcast

Latest Metabasis Therapeutics Stories

2008-11-03 09:00:07

Metabasis Therapeutics (Nasdaq: MBRX) announced today that an oral presentation summarizing the results from the Company's Phase 2a clinical trial for MB07803 was given at the World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy), in Barcelona, Spain. MB07803 is the Company's second-generation fructose-1,6-bisphosphatase (FBPase) inhibitor discovered and developed internally for the treatment of type 2 diabetes. MB07803 was found to be safe and well...

2008-09-24 09:00:49

Metabasis Therapeutics, a biopharmaceutical company, has initiated a clinical trial to evaluate higher doses of MB07803 in patients. MB07803 is Metabasis's second-generation FBPase inhibitor product candidate for the treatment of type 2 diabetes. The trial is expected to enroll at least 40 patients. A major milestone was achieved earlier in 2008 with the completion of the Phase IIa, 28-day proof-of-concept trial for MB07803, said Metabasis. This clinical trial provided promising results...

2008-07-29 18:00:20

Metabasis Therapeutics (Nasdaq: MBRX) announced today that an oral presentation summarizing the results from the Company's Phase 2a clinical trial for MB07803 will be given at the World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy), to be held in Barcelona, Spain, October 30 to November 2, 2008. MB07803 is the Company's second-generation fructose-1,6-bisphosphatase (FBPase) inhibitor for the treatment of type 2 diabetes. As reported in April,...

2008-06-16 12:01:05

Metabasis Therapeutics (Nasdaq: MBRX), announced today that Dr. Paul Laikind, president and chief executive officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York, NY. Dr. Laikind is scheduled to present on Thursday, June 26 at 11:45 a.m. Eastern Time and is expected to provide an overview of the Company and its product candidates. The Company's presentation will be webcast. To access the live broadcast and the subsequent archived recording and of the...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related